Advertisement

Topics

Smallpox BioSecurity Company Profile

21:01 EDT 25th September 2018 | BioPortfolio

Nil


News Articles [94 Associated News Articles listed on BioPortfolio]

Smallpox Treatment Approved

The FDA has approved its first treatment for smallpox. Smallpox was eradicated in 1980, so tecovirimat (TPOXX) is intended to be used if smallpox is...

FDA approves drug to treat smallpox, just in case

Smallpox has been eradicated, but it could be used in a biological attack.

FDA Approves TPOXX To Be The First Drug For Smallpox

"You have smallpox," are 3 words that you never want to hear. But having a treatment available like this one manufactured by SIGA Technologies is still quite important.

FDA Approves TPOXX To Be The 1st Drug For Smallpox

"You have smallpox," are 3 words that you never want to hear. But having a treatment available like this one manufactured by SIGA Technologies is still quite important.

FDA Approves TPOXX (tecovirimat) as the First Drug for the Treatment of Smallpox

July 13, 2018 -- The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Organization declared sm...

FDA approves first smallpox therapy

US regulators have approved the first treatment designed to mitigate the impact of a potential outbreak of smallpox caused by bioterrorism.

US FDA approves first treatment for smallpox to protect against bioterrorism

The first ever drug to treat smallpox has been approved by the US FDA, after having been created by SIGA Therapeutics in coordination with several US departments.

Immunosuppression, Past Vaccines, and Smallpox Reemergence

Has the immunologic status of the population played a role in the re-emergence of the smallpox virus? Emerging Infectious Diseases

Drugs and Medications [0 Results]

None

PubMed Articles [45 Associated PubMed Articles listed on BioPortfolio]

The geography of smallpox in England before vaccination: A conundrum resolved.

Smallpox is regarded as an ancient and lethal disease of humans, however very little is known about the prevalence and impact of smallpox before the advent of vaccination (c.1800). Here we use evidenc...

Smallpox vaccine complications: the dermatologist's role in diagnosis and management.

In 2002, the United States implemented a new program for smallpox vaccinations among military personnel using a live vaccinia virus product. Approximately 2.4 million US military service members and h...

Tecovirimat: First Global Approval.

Tecovirimat (TPOXX) is an orthopoxvirus-specific antiviral drug developed by SIGA Technologies in conjunction with the US Department of Health and Human Services' Biomedical Advances Research and Deve...

Oral Tecovirimat for the Treatment of Smallpox.

Background Smallpox was declared eradicated in 1980, but variola virus (VARV), which causes smallpox, still exists. There is no known effective treatment for smallpox; therefore, tecovirimat is being ...

Import volumes and biosecurity interventions shape the arrival rate of fungal pathogens.

Global trade and the movement of people accelerate biological invasions by spreading species worldwide. Biosecurity measures seek to allow trade and passenger movements while preventing incursions tha...

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

The purpose of this study is to examine the safety and the effectiveness of a new vaccine for the prevention of the disease, smallpox.

Safety and Efficacy of CJ-50300 in Healthy Volunteers

The currently available stock of smallpox vaccine would be insufficient in the face of an incident of smallpox attack. Thus, new manufacturing methods for smallpox vaccine are urgently nee...

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

The purpose of this study is to see how many people respond to a smallpox vaccine when a sore forms where the shot was given. The world was declared free of smallpox in 1980. General rou...

Safety and Immunogenicity of CJ-50300

The currently available stock of smallpox vaccine would be insufficient in the face of an incident of smallpox attack. Thus, new manufacturing methods for smallpox vaccine is urgently need...

Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults

Primary Objective: To estimate the smallpox vaccination take rate in healthy young adults not previously vaccinated with a smallpox vaccine. Secondary Objectives: To describ...

Companies [17 Associated Companies listed on BioPortfolio]

Smallpox BioSecurity

Nil

Alliance for Biosecurity

The Alliance for Biosecurity was formed in June of 2005 by biopharmaceutical companies and the Center for Biosecurity of the University of Pittsburgh Medical Center. Alliance members are committed to...

Center for Biosecurity of UPMC

Omrix Biopharmaceuticals

We aim to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly in the areas of biosurgical and passive immunot...

CosmosID™, Inc.

CosmosID™, Inc. is a privately owned company based in College Park, MD that provides pathogen diagnostic software solutions for rapid identification of pathogens, antibiotic ...

More Information about "Smallpox BioSecurity" on BioPortfolio

We have published hundreds of Smallpox BioSecurity news stories on BioPortfolio along with dozens of Smallpox BioSecurity Clinical Trials and PubMed Articles about Smallpox BioSecurity for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Smallpox BioSecurity Companies in our database. You can also find out about relevant Smallpox BioSecurity Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record